Abstract :

Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability in older adults. Knee osteoarthritis, a major subtype, closely resembles Waja’-al-Rukba described in Unani medicine, both sharing chronicity, pain, stiffness, and restricted mobility. Unani scholars attribute its origin to Sū’-i-Mizāj (abnormal temperament) and accumulation of Mawād-e-Fuzūni (morbid material) in joints.

Our aim is to evaluate the relationship between Mizāj (temperament) and biochemical markers of inflammation and metabolism (CRP, uric acid, BMI) in patients with Waja’-al-Rukba (knee pain), and to assess their role in disease risk and progression.

A cross-sectional study was conducted on 75 patients (aged 40–80 years) attending the OPD and IPD of of Ilaj bit Tadbeer and Moalejat in Ajmal Khan Tibbiya College and hospital, Ajmal Khan Tibbiya College, AMU, Aligarh. Mizāj was assessed using standard Unani parameters. Laboratory investigations included ESR, CRP, uric acid and BMI.

In our study we have find that most of the patients (76%) were aged between 40–50 years with females predominance (89%). Balghamī Mizāj (phlegmatic) was the most common temperament (41%), followed by Ṣafrāwī (27%), Damawī (20%), and Sawdāwī (12%). Balghamī individuals had the highest mean BMI (27–29.6 kg/m²) and mean uric acid level (5.98 ± 0.9 mg/dl). CRP positivity was also highest in the Balghamī group (12 cases). These findings indicate a strong association of Balghamī Mizāj with obesity, hyperuricemia, and inflammation.

The study demonstrates a significant correlation between Mizāj (temperament) and metabolic–inflammatory markers, validating Unani concepts through modern biomedical parameters. Balghamī temperament predisposes individuals to inflammatory and metabolic derangements such as osteoarthritis, supporting the integration of Unani temperament-based assessment in preventive and therapeutic frameworks.

---

Keywords :

C-reactive protein, Mizāj, Unani Medicine, Uric acid, Waja’-al-Rukba.

---

References :

1. (2007). The canon of medicine (pp. 219–229). New Delhi, India: Idara Kitab-us-Shifa.
2. Blagojevic, M., Jinks, C., Jeffery, A., & Jordan, K. P. (2010). Risk factors for onset of osteoarthritis of the knee in older adults: A systematic review and meta-analysis. Osteoarthritis and Cartilage, 18(1), 24–33.
3. Central Council for Research in Unani Medicine. (2012). Standard Unani terminology (pp. 36–38, 144–146, 171–174). New Delhi, India: Ministry of AYUSH.
4. Cui, A., Li, H., Wang, D., Zhong, J., Chen, Y., & Lu, H. (2020). Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine, 29–30, 100587.
5. Felson, D. T. (2006). Clinical practice: Osteoarthritis of the knee. New England Journal of Medicine, 354(8), 841–848.
6. Firestein, G. S., Budd, R. C., Gabriel, S. E., McInnes, I. B., & O’Dell, J. R. (2017). Kelley and Firestein’s textbook of rheumatology (10th ed., p. 128). Philadelphia, PA: Elsevier.
7. Global Burden of Disease Collaborative Network. (2020). Global Burden of Disease Study 2019 (GBD 2019) results: Osteoarthritis, level 3 cause. Seattle, WA: Institute for Health Metrics and Evaluation (IHME).
8. Global Health Data Exchange. (2019). Global Burden of Disease Study 2019 (GBD 2019) data resources. Seattle, WA: Global Health Data Exchange. https://ghdx.healthdata.org/gbd-2019
9. Han, T. S., Sattar, N., & Lean, M. (2006). Assessment of obesity and its clinical implications. BMJ, 333(7570), 695–698.
10. Hanna, F. S., Teichtahl, A. J., Wluka, A. E., Wang, Y., Urquhart, D. M., English, D. R., et al. (2009). Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: A gender study of adults without clinical knee osteoarthritis. Menopause, 16(4), 666–670.
11. Hunter, D. J., & Bierma-Zeinstra, S. (2019). Osteoarthritis. The Lancet, 393(10182), 1745–1759.
12. Sina I. (1993). Al-Qanun fi’l-Tibb (Canon of Medicine) (Vol. 2, p. 112). New Delhi, India: Jamia Hamdard.
13. Irfan, M., Raheem, M. S. A., & Sharma, R. K. (2025). Role of Unani medicine in geriatric care: A holistic approach to healthy ageing. International Journal of Medical Sciences and Pharma Research, 11(2), 32–41.
14. Itrat, M., Nigar, Z., & Haque, N. (2013). Concept of aging in Unani medicine. International Journal of Research in Ayurveda and Pharmacy, 4(3), 459–462.
15. Jurjani, A. H. (2010). Zakhira Khawarzam Shahi (Vol. 1, Urdu trans.). New Delhi, India: Central Council for Research in Unani Medicine.
16. Jurjani, A. H. (2010). Zakhira Khwarazm Shahi (Vol. 4, Urdu trans., p. 221). New Delhi, India: Central Council for Research in Unani Medicine.
17. Jurjani, I. (2010). Zakheera Khawarzam Shahi (Vol. 2, Part 6, Urdu trans. by H. H. Khan, pp. 641–642). New Delhi, India: Idara Kitab-us-Shifa.
18. Jurjani, I. (2010). Zakheera Khwarzam Shahi (Vol. 6, Urdu trans. by H. H. Khan). New Delhi, India: Idara Kitab-us-Shifa.
19. Kabiruddin, H. M. (1954). Kulliyat-e-Nafisi. Hyderabad, India: Idara Kitab-us-Shifa.
20. Kasper, D. L., Fauci, A. S., Hauser, S. L., Longo, D. L., Jameson, J. L., & Loscalzo, J. (2018). Harrison’s principles of internal medicine (20th ed., p. 102). New York, NY: McGraw Hill.
21. Lopez, J. (2013). Review of “Tietz textbook of clinical chemistry and molecular diagnosis” (5th ed., C. A. Burtis, E. R. Ashwood, & D. E. Bruns, Eds.). Indian Journal of Clinical Biochemistry, 28(1), 104–105.
22. Pal, C. P., Singh, P., Chaturvedi, S., Pruthi, K. K., & Vij, A. (2016). Epidemiology of knee osteoarthritis in India and related factors. Indian Journal of Orthopaedics, 50(5), 518–522.
23. Razi, Z. (2001). Kitab al-Hawi (Vol. 1, Urdu trans., pp. 30–35). New Delhi, India: Central Council for Research in Unani Medicine.
24. Razi, Z. (2001). Kitab al-Hawi (Liber Continens) (Vol. 3, Urdu trans., p. 355). New Delhi, India: Central Council for Research in Unani Medicine.
25. Schmitz, P. G., & Martin, K. J. (2008). Internal medicine: Just the facts (Section 15, Rheumatology, Chapter 129, Osteoarthritis, pp. 754–757). New York, NY: McGraw-Hill Medical.
26. Sharma, L. (2021). Osteoarthritis of the knee. New England Journal of Medicine, 384(1), 51–59.
27. Sina, I. (2015). Kulliyāt Qanoon (Vol. II, p. 202). New Delhi, India: Idara Kitab-us-Shifa.
28. Sina, I. (1993). Al-Qanun fi’l-Tibb (Book I, Fen I, Maqalah 1, English trans.). New Delhi, India: Jamia Hamdard.
29. Sowers, M. (2001). Epidemiology of risk factors for osteoarthritis: Systemic factors. Current Opinion in Rheumatology, 13(5), 447–451.
30. Srikanth, V. K., Fryer, J. L., Zhai, G., Winzenberg, T. M., Hosmer, D., & Jones, G. (2005). A meta-analysis of sex differences in prevalence, incidence, and severity of osteoarthritis. Osteoarthritis and Cartilage, 13(9), 769–781.
31. Tillett, W. S., & Francis, T. (1930). Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. Journal of Experimental Medicine, 52(4), 561–571.
32. Warrell, D. A., Cox, T. M., & Firth, J. D. (Eds.). (2010). Oxford textbook of medicine (5th ed., pp. 12–15). Oxford, UK: Oxford University Press.
33. World Health Organization. (1995). Physical status: The use and interpretation of anthropometry (WHO Technical Report Series 854). Geneva, Switzerland: World Health Organization. https://www.who.int/publications/i/item/9241208546
34. World Health Organization. (2000). Obesity: Preventing and managing the global epidemic (WHO Technical Report Series No. 894). Geneva, Switzerland: World Health Organization. https://iris.who.int/handle/10665/42330
35. Zaidi, Z., Nazir, S., Bano, U., Nasir, A., & Jabeen, F. (2022). Suranjan—A potent antiarthritic drug of Unani medicine for geriatric population. Annals of Geriatrics Education and Medical Sciences, 9(2), 40–43.
36. Zhang, Y., & Jordan, J. M. (2010). Epidemiology of osteoarthritis. Clinical Geriatrics Medicine, 26(3), 355–369.